The basal-like subtypes of breast cancer are negative for the expression of ER, PR, and HER2 (ER–/PR–/HER2–) and express CK5, CK6, CK14, CK17 [5, 9, 10]. This evidence concerns the gene ERBB2 and breast carcinoma.